Finance

Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
US$ १.८५
-१.६०%
(-०.०३०) 1D
US$ १.८५
०.००% (०.००)
After hours
Closed: अक्टोबर ७, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Open
US$ १.८७
High
US$ १.९२
Low
US$ १.८३
Mkt. cap
४.८६ करोड
Avg. vol.
३.४३ लाख
Volume
१.३९ लाख
52-wk high
US$ १६.००
52-wk low
US$ १.७२
EPS
-US$ २.१८
Beta
१.३२
Shares outstanding
२.६३ करोड
No. of employees
३३
Open
US$ १.८७
High
US$ १.९२
Low
US$ १.८३
Mkt. cap
४.८६ करोड
Avg. vol.
३.४३ लाख
Volume
१.३९ लाख
52-wk high
US$ १६.००
52-wk low
US$ १.७२
EPS
-US$ २.१८
Beta
१.३२
Shares outstanding
२.६३ करोड
No. of employees
३३
News stories
From web sources and news partners
TradingView
TradingView
·
२६ मिनेट पहिले
Winklevoss Zcash ETF Filing Brings Privacy Coin Exposure To Nasdaq
The Business Journals
The Business Journals
·
२७ मिनेट पहिले
Wilsonville co. shifts to OTC, pursues NYSE review, deal options
About Elicio Therapeutics Inc
CEO-
Employees३३
Founded२०११
Headquartersबोस्टन, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websiteelicio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ELTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current US$ १.८५
US$ २३.०० (+१,१४३.२४%)
Average
US$ १५.५० (+७३७.८४%)
Lowest
US$ ८.०० (+३३२.४३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$ ८.००
+३३२.४%
09/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ २३.००
+१,१४३.२%
08/21/2026
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
08/17/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
US$ १२.००
+५४८.६%
06/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
US$ २०.००
+९८१.१%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$ १८.००
+८७३%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ १७.००
+८१८.९%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
५०.३९ लाख
५०.८० लाख
६७.५७ लाख
६८.११ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३०.०६ लाख
३७.६२ लाख
३८.४५ लाख
३६.१८ लाख
Operating expense
८०.४५ लाख
८८.४२ लाख
१.०६ करोड
१.०४ करोड
Total operating expenses
८०.४५ लाख
८८.४२ लाख
१.०६ करोड
१.०४ करोड
Operating income
-८०.४५ लाख
-८८.४२ लाख
-१.०६ करोड
-१.०४ करोड
Other non operating income
-१८.११ लाख
१२.६२ लाख
-९.८४ लाख
२४.८३ लाख
EBT including unusual items
-१.०१ करोड
-७७.१८ लाख
-१.१८ करोड
-८२.१७ लाख
EBT excluding unusual items
-१.०१ करोड
-७७.१८ लाख
-१.१८ करोड
-८२.१७ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.०१ करोड
-७७.१८ लाख
-१.१८ करोड
-८२.१७ लाख
Net profit margin
-
-
-
-
Earnings per share
-०.६०
-०.४९
-०.६५
-०.४३
Interest and investment income
१.९९ लाख
१.९९ लाख
१.५७ लाख
१.३८ लाख
Interest expense
-४.२६ लाख
-३.३७ लाख
-४.०७ लाख
-४.१० लाख
Net interest expenses
-२.२७ लाख
-१.३८ लाख
-२.५० लाख
-२.७२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-७९.९६ लाख
-८७.९३ लाख
-१.०६ करोड
-१.०४ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू